CGEN files Rule 144 to sell 2,000 shares

CGEN submitted a Rule 144 notice reporting an intended sale of 2,000 ordinary shares under an Employee Stock Options plan, with the sale dated 04/14/2026 and listed as Cash - Upon Exercise.

Rhea-AI Filing Summary

CGEN submitted a Rule 144 notice reporting an intended sale of 2,000 ordinary shares under an Employee Stock Options plan, with the sale dated 04/14/2026 and listed as Cash - Upon Exercise. The filing also lists a prior sale of 26,375 shares on 03/26/2026 generating $58,657.50.

Key Figures

Intended shares to be sold: 2,000 shares Recent sale (past 3 months): 26,375 shares Proceeds from prior sale: $58,657.50 +2 more

5 metrics

Intended shares to be sold 2,000 shares Sale dated 04/14/2026 under Employee Stock Options plan

Recent sale (past 3 months) 26,375 shares Sale dated 03/26/2026 listed under securities sold in past 3 months

Proceeds from prior sale $58,657.50 Proceeds tied to 26,375-share sale on 03/26/2026

Plan date 08/03/2023 Employee Stock Options plan date shown in the filing

Broker listed Oppenheimer & Co. Inc Brokerage firm associated with the securities entry

Key Terms

Rule 144 / Form 144, Employee Stock Options plan, Cash - Upon Exercise

3 terms

Rule 144 / Form 144 regulatory

"Filer Information | 144: Filer Information"

Employee Stock Options plan financial

"Securities To Be Sold | Employee Stock Options plan"

Cash - Upon Exercise financial

"Securities To Be Sold | Cash - Upon Exercise"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CGEN's Form 144 say about shares to be sold?

The Form 144 reports an intended sale of 2,000 ordinary shares under an Employee Stock Options plan, dated 04/14/2026. The filing labels the transaction method as Cash - Upon Exercise, indicating the shares stem from option exercise proceeds.

Did CGEN report any recent sales in the past three months?

Yes. The filing shows a sale on 03/26/2026 of 26,375 ordinary shares that produced proceeds of $58,657.50. This prior sale is listed separately from the intended 2,000-share transaction on 04/14/2026.

Under what plan are the 2,000 shares being sold for CGEN?

The 2,000 shares are tied to an Employee Stock Options plan with an original plan date of 08/03/2023 shown in the filing. The sale method is recorded as Cash - Upon Exercise, consistent with option exercises.

Who is the broker or intermediary listed in the filing?

The filing lists Oppenheimer & Co. Inc at 85 Broad St., New York, NY in connection with the securities information, including the 2,000-share entry dated 04/14/2026. No further broker terms are detailed in the excerpt.

How much proceeds were reported for the March 26, 2026 sale?

The March 26, 2026 sale of 26,375 shares is reported with proceeds of $58,657.50. The filing lists that sale under "Securities Sold During The Past 3 Months" as a completed transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 06:16 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001972527
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COMPUGEN LTD
SEC File Number	000-30902
Address of Issuer	26 HAROKMIM STREET BUILDING D HOLON ISRAEL 5885849
Phone	011-972-3-765-8585
Name of Person for Whose Account the Securities are To Be Sold	Levine Zurit
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc 85 Broad St. New York NY 10004	2000	5520.00	94553191	04/14/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/03/2023	Employee Stock Options plan	Issuer			2000	04/14/2026	Cash - Upon Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Levine Zurit 26 HAROKMIM STREET Holon L3 5885849	Ordinary	03/26/2026	26375	58657.50

144: Remarks and Signature

Remarks	Under a 10b5-1 sale plan adopted on 12/24/2025
Date of Notice	04/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Levine Zurit
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)